Skip to main content
. 2015 Aug 18;6(30):30232–30238. doi: 10.18632/oncotarget.4920

Figure 1. Progression free survival and overall survival among all 703 gliomas.

Figure 1

A. Progression free survival and overall survival among all 703 gliomas stratified by IDH1/2 mutant status; B. Progression free survival and overall survival among all 703 gliomas stratified by relative Ki-67 expression level.